FENNEC PHARMACEUTICALS INC.

FENC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $28.3M $3.9M $942.0K $2.3M $1.7M $2.3M $5.3M $5.9M
Accounts Receivable
Inventory
Total Current Assets
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $28.4M $4.0M $1.0M $2.4M $1.8M $2.4M $5.4M $6.0M
Liabilities
Accounts Payable $855.0K $244.0K $297.0K $308.0K $212.0K $259.0K $342.0K $272.0K
Total Current Liabilities $1.6M $402.0K $471.0K $1.8M $3.2M $7.3M $5.5M $10.9M
Long-Term Debt
Total Liabilities $1.6M $402.0K $471.0K $1.8M $3.2M $7.3M $5.5M $10.9M
Stockholders' Equity
Retained Earnings $-121.4M $-114.3M $-111.5M $-110.9M $-108.7M
Total Stockholders' Equity $26.8M $3.6M $548.0K $613.0K $-1.5M $-5.0M $-119.0K $-4.9M
← Newer Page 2 of 4 Older →